These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28521015)

  • 21. Relapse prevention interventions for smoking cessation.
    Livingstone-Banks J; Norris E; Hartmann-Boyce J; West R; Jarvis M; Hajek P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003999. PubMed ID: 30758045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.
    Ray LA; Green R; Enders C; Leventhal AM; Grodin EN; Li G; Lim A; Hartwell E; Venegas A; Meredith L; Nieto SJ; Shoptaw S; Ho D; Miotto K
    Am J Psychiatry; 2021 Sep; 178(9):818-828. PubMed ID: 34080890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES.
    West R; Evins AE; Benowitz NL; Russ C; McRae T; Lawrence D; St Aubin L; Krishen A; Maravic MC; Anthenelli RM
    Addiction; 2018 Aug; 113(8):1507-1516. PubMed ID: 29508470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are recent attempts to quit smoking associated with reduced drinking in England? A cross-sectional population survey.
    Brown J; West R; Beard E; Brennan A; Drummond C; Gillespie D; Hickman M; Holmes J; Kaner E; Michie S
    BMC Public Health; 2016 Jul; 16():535. PubMed ID: 27443348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of stop-smoking medications in the United States before and after the introduction of varenicline.
    Kasza KA; Cummings KM; Carpenter MJ; Cornelius ME; Hyland AJ; Fong GT
    Addiction; 2015 Feb; 110(2):346-55. PubMed ID: 25331778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine metabolite ratio and smoking outcomes using nicotine replacement therapy and varenicline among smokers with and without psychiatric illness.
    Clyde M; Pipe A; Els C; Reid R; Fu A; Clark A; Tulloch H
    J Psychopharmacol; 2018 Sep; 32(9):979-985. PubMed ID: 29788791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential.
    Versace F; Stevens EM; Robinson JD; Cui Y; Deweese MM; Engelmann JM; Green CE; Karam-Hage M; Lam CY; Minnix JA; Wetter DW; Cinciripini PM
    Nicotine Tob Res; 2019 Jan; 21(2):234-240. PubMed ID: 29220524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.
    Martin RA; Rohsenow DJ; Tidey JW
    J Subst Abuse Treat; 2019 Sep; 104():22-27. PubMed ID: 31370981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of varenicline and nicotine replacement therapy in people with and without general practitioner-recorded dementia: retrospective cohort study of routine electronic medical records.
    Itani T; Martin R; Rai D; Jones T; Taylor G; Thomas K; Munafo M; Davies N; Taylor A
    BMJ Open; 2019 Aug; 9(8):e027569. PubMed ID: 31473613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records.
    Davies NM; Taylor GMJ; Taylor AE; Jones T; Martin RM; Munafò MR; Windmeijer F; Thomas KH
    Addiction; 2018 Jun; 113(6):1105-1116. PubMed ID: 29460494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing varenicline dose in smokers who do not respond to the standard dosage: a randomized clinical trial.
    Hajek P; McRobbie H; Myers Smith K; Phillips A; Cornwall D; Dhanji AR
    JAMA Intern Med; 2015 Feb; 175(2):266-71. PubMed ID: 25545858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time.
    Stepankova L; Kralikova E; Zvolska K; Pankova A; Adamcekova Z; Kuhn M; Noland D
    Addiction; 2021 Feb; 116(2):346-355. PubMed ID: 32592219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation.
    Jackson SE; McGowan JA; Ubhi HK; Proudfoot H; Shahab L; Brown J; West R
    Addiction; 2019 May; 114(5):787-797. PubMed ID: 30614586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
    Chen LS; Baker TB; Miller JP; Bray M; Smock N; Chen J; Stoneking F; Culverhouse RC; Saccone NL; Amos CI; Carney RM; Jorenby DE; Bierut LJ
    Clin Pharmacol Ther; 2020 Dec; 108(6):1315-1325. PubMed ID: 32602170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.
    Rosen LJ; Galili T; Kott J; Goodman M; Freedman LS
    Addiction; 2018 May; 113(5):805-816. PubMed ID: 29377409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study.
    Ferguson SG; Brown J; Frandsen M; West R
    Addiction; 2015 Mar; 110(3):513-8. PubMed ID: 25393225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials.
    Agboola SA; Coleman T; McNeill A; Leonardi-Bee J
    Addiction; 2015 Jul; 110(7):1182-93. PubMed ID: 25846123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trial.
    Gobarani RK; Abramson MJ; Bonevski B; Weeks GR; Dooley MJ; Smith BJ; Veale A; Webb A; Kirsa S; Thomas D; Miller A; Gasser R; Paul E; Parkinson J; Meanger D; Coward L; Kopsaftis Z; Rofe O; Lee P; George J
    BMJ Open; 2020 Oct; 10(10):e038184. PubMed ID: 33028555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.